Combo therapy effective in colorectal cancer therapy, study shows

01/21/2010 | Reuters

A study showed that cancer drug Xeloda combined with Xelox proved more effective than the combination of chemotherapy drugs 5-fluorouracil and leucovorin in improving disease-free survival among elderly patients with colorectal cancer. Xeloda is approved as a monotherapy for those with early-stage colon cancer.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI